相关实验视频

Updated: Jun 7, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

精密瘤学平台:在癌症治疗中利用基因组数据库的实际策略

Antonia A Gazola¹, William Lautert-Dutra², Leticia Frohlich Archangelo³

¹School of Medicine, Pontifical Catholic University of Rio Grande do Sul - PUCRS, Av. Ipiranga, 668, Porto Alegre, RS, 90619-900, Brazil.

Molecular cytogenetics

|November 15, 2024

概括

精密瘤学软件通过分析瘤突变来帮助癌症治疗决策. 我的癌症基因组和OncoKB是识别可操作的生物标志物和指导治疗选择的最佳选择.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

分子向疗法和下一代测序 (NGS) 已经推进了精确瘤学.
现在可以更容易地对瘤进行基因组分析,从而能够快速识别可操作的突变.

研究的目的:

审查精密瘤学软件的实用性,准确性和全面性.
引导瘤学家和研究人员选择合适的工具来解释体质生物标志物数据.

主要方法:

评估和分类几种在线临床决策工具和癌症数据库.
根据内容,实用性和实践指南对体生体标志物解释进行评估平台.
分析了案例研究,以说明这些工具对治疗计划的影响.

主要成果:

确定了用于遗传生物标志物搜索的全面,主要是开放式访问平台.
MyCancerGenome和OncoKB被确定为体质突变临床意义的最佳选择.
大多数评估的软件可以集成到临床工作流程中,以获得最新的药物和试验信息.

结论:

精准瘤学软件对于及时准确的癌症治疗决策至关重要.
用户友好性和更新的一致性在不同平台上有所不同.
未来的改进,包括人工智能,将改善整合和预测准确性.

关键词:

可以采取行动的突变.人工智能的人工智能是人工智能.大数据集成的大数据集成癌症生物标志物癌症生物标志物化疗化疗是一种化学疗法.对DNA突变分析进行分析.瘤基因是一种瘤基因.瘤学软件瘤学软件个性化癌症治疗个性化癌症治疗瘤抑制基因的基因

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...